PL1948606T3 - 3,5-dwupodstawione fenylopiperydyny jako modulatory neurotransmisji dopaminy - Google Patents
3,5-dwupodstawione fenylopiperydyny jako modulatory neurotransmisji dopaminyInfo
- Publication number
- PL1948606T3 PL1948606T3 PL06806224T PL06806224T PL1948606T3 PL 1948606 T3 PL1948606 T3 PL 1948606T3 PL 06806224 T PL06806224 T PL 06806224T PL 06806224 T PL06806224 T PL 06806224T PL 1948606 T3 PL1948606 T3 PL 1948606T3
- Authority
- PL
- Poland
- Prior art keywords
- piperidines
- modulators
- disubstituted phenyl
- dopamine neurotransmission
- neurotransmission
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
- C07D211/24—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by sulfur atoms to which a second hetero atom is attached
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4418—Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Psychology (AREA)
- Addiction (AREA)
- Anesthesiology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0502254A SE529246C2 (sv) | 2005-10-13 | 2005-10-13 | Nya disubstituerade fenyl-piperidiner som modulatorer för dopaminneurotransmission |
| EP06806224A EP1948606B1 (en) | 2005-10-13 | 2006-10-12 | 3, 5-disubstituted phenyl-piperidines as modulators of dopamine neurotransmission |
| PCT/EP2006/009866 WO2007042295A1 (en) | 2005-10-13 | 2006-10-12 | 3, 5-disubstituted phenyl-piperidines as mdulators of dopamine? neurotransmission |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL1948606T3 true PL1948606T3 (pl) | 2011-08-31 |
Family
ID=37467527
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL06806224T PL1948606T3 (pl) | 2005-10-13 | 2006-10-12 | 3,5-dwupodstawione fenylopiperydyny jako modulatory neurotransmisji dopaminy |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US8501777B2 (pl) |
| EP (1) | EP1948606B1 (pl) |
| JP (1) | JP4857346B2 (pl) |
| KR (1) | KR20080046720A (pl) |
| CN (1) | CN101273014B (pl) |
| AT (1) | ATE494277T1 (pl) |
| AU (1) | AU2006301432B2 (pl) |
| BR (1) | BRPI0617355A2 (pl) |
| CA (1) | CA2625663A1 (pl) |
| DE (1) | DE602006019470D1 (pl) |
| DK (1) | DK1948606T3 (pl) |
| ES (1) | ES2358537T3 (pl) |
| HK (1) | HK1125097A1 (pl) |
| HR (1) | HRP20110196T1 (pl) |
| IL (1) | IL189298A0 (pl) |
| MY (1) | MY143241A (pl) |
| NO (1) | NO20082174L (pl) |
| NZ (1) | NZ566015A (pl) |
| PL (1) | PL1948606T3 (pl) |
| RU (1) | RU2418787C2 (pl) |
| SE (1) | SE529246C2 (pl) |
| UA (1) | UA93380C2 (pl) |
| WO (1) | WO2007042295A1 (pl) |
| ZA (1) | ZA200802238B (pl) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9904723D0 (sv) | 1999-12-22 | 1999-12-22 | Carlsson A Research Ab | New modulators of dopamine neurotransmission II |
| SE0401465D0 (sv) | 2004-06-08 | 2004-06-08 | Carlsson A Research Ab | New substituted piperdines as modulators of dopamine neurotransmission |
| MXPA06013944A (es) | 2004-06-08 | 2007-10-08 | Neurosearch Sweden Ab | Nuevas fenilpiperidinas/piperazinas disustituidas como moduladores de la neurotransmision de dopamina. |
| US7851629B2 (en) | 2004-06-08 | 2010-12-14 | Nsab, Filial Af Neurosearch Sweden Ab, Sverige | Disubstituted phenylpiperidines as modulators of dopamine and serotonin neurotransmission |
| MX2007004215A (es) | 2004-10-13 | 2007-12-12 | Neurosearch Sweden Ab | Proceso para la sintesis de 4-(3-metansulfonilfenil)-1-n- propilpiperidina. |
| DK2146961T3 (da) * | 2007-04-12 | 2014-04-28 | Ivax Int Gmbh | N-oxid- og/eller di-N-oxidderivater af dopaminreceptorstabilisatorer/modulatorer udvisende forbedrede cardiovaskulære bivirkningsprofiler |
| DK2271638T3 (da) * | 2008-04-29 | 2011-11-28 | Nsab Af Neurosearch Sweden Ab | Modulatorer af dopaminneurotransmission |
| JP2011519839A (ja) * | 2008-04-29 | 2011-07-14 | エヌエスエイビー、フィリアル アヴ ノイロサーチ スウェーデン エービー、スヴェーリエ | ドーパミン神経伝達のモジュレーター |
| CA2722978A1 (en) * | 2008-04-29 | 2009-11-05 | Nsab, Filial Af Neurosearch Sweden Ab, Sverige | Modulators of dopamine neurotransmission |
| WO2011107583A1 (en) | 2010-03-04 | 2011-09-09 | Nsab, Filial Af Neurosearch Sweden Ab, Sverige | Substituted 4-phenyl-n-alkyl-piperidines for preventing onset or slowing progression of neurodegenerative disorders |
| SG10201506761XA (en) | 2010-09-03 | 2015-10-29 | Teva Pharmaceuticals Int Gmbh | Deuterated analogs of pridopidine useful as dopaminergic stabilizers |
| EP2753603B1 (en) | 2011-09-07 | 2017-06-21 | Teva Pharmaceuticals International GmbH | Polymorphic form of pridopidine hydrochloride |
| CA2856749A1 (en) | 2011-12-08 | 2013-06-13 | IVAX International GmbH | The hydrobromide salt of pridopidine |
| EP2844346B1 (en) | 2012-04-04 | 2020-01-01 | Prilenia Neurotherapeutics Ltd. | Pharmaceutical compositions for combination therapy |
| TW201613859A (en) * | 2014-06-30 | 2016-04-16 | Teva Pharma | Analogs of PRIDOPIDINE, their preparation and use |
| JP7278210B2 (ja) | 2016-08-24 | 2023-05-19 | プリレニア ニューロセラピューティクス リミテッド | ジストニアを治療するためのプリドピジンの使用 |
| MX2020002645A (es) * | 2017-09-08 | 2021-06-10 | Prilenia Neurotherapeutics Ltd | Pridopidina para el tratamiento de las discinesias inducidas por fármacos. |
Family Cites Families (49)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB850662A (en) | 1956-10-22 | 1960-10-05 | Parke Davis & Co | Substituted piperazines and processes for their production |
| BE662455A (pl) | 1964-04-14 | |||
| FR1459013A (fr) | 1964-08-05 | 1966-04-29 | Allen & Hanburys Ltd | Procédé de préparation de dérivés de la 4-phényl-pipéridine |
| GB1060160A (en) | 1964-08-05 | 1967-03-01 | Allen & Hanburys Ltd | 4-phenylpiperidine derivatives |
| US3539573A (en) | 1967-03-22 | 1970-11-10 | Jean Schmutz | 11-basic substituted dibenzodiazepines and dibenzothiazepines |
| ZA7546B (en) | 1974-01-21 | 1976-08-25 | Parke Davis & Co | New antibacterial amide compounds and methods for their production |
| GB1560271A (en) | 1977-01-14 | 1980-02-06 | Joullie International Sa | Therapeutically useful m-trifluoromethylphenylpiperazine derivatives |
| US4202898A (en) | 1978-06-05 | 1980-05-13 | Synthelabo | Method of treating anxiety and depression |
| FR2459797A2 (fr) | 1978-08-01 | 1981-01-16 | Synthelabo | Derives de phenyl-1 piperazine et leur application en therapeutique |
| US4333942A (en) | 1979-08-03 | 1982-06-08 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Anti-depressant and analgesic 4-phenoxypiperidines |
| US4518712A (en) | 1980-06-30 | 1985-05-21 | Taiho Pharmaceutical Company Limited | Piperazine derivative and analgesic composition containing the same |
| GB2083476B (en) | 1980-09-12 | 1984-02-08 | Wyeth John & Brother Ltd | Heterocyclic compounds |
| FR2501506A1 (fr) | 1981-03-11 | 1982-09-17 | Sanofi Sa | Compositions pharmaceutiques a action anorexigene contenant des derives de la tetrahydropyridine |
| US4415736A (en) | 1981-12-28 | 1983-11-15 | E. I. Du Pont De Nemours & Co. | Certain tetrahydropyridine intermediates |
| ATE50987T1 (de) | 1982-05-10 | 1990-03-15 | Takeda Chemical Industries Ltd | Dihydropyridinderivate, deren herstellung und verwendung. |
| US4504660A (en) | 1982-07-06 | 1985-03-12 | American Home Products Corporation | Process for the production of 2,6-diaminobenzonitrile derivatives |
| HU198454B (en) | 1987-12-14 | 1989-10-30 | Richter Gedeon Vegyeszet | Process for production of new derivatives of tetrahydrospiridin and medical compositions containing these compounds |
| FR2639226B1 (fr) | 1988-11-18 | 1993-11-05 | Sanofi | Utilisation de trifluoromethylphenyltetrahydropyridines pour la preparation de medicaments destines a combattre les troubles anxio-depressifs |
| CA2071897A1 (en) | 1989-12-28 | 1991-06-29 | Richard A. Glennon | Sigma receptor ligands and the use thereof |
| EP0641320B1 (en) | 1991-04-17 | 2001-05-30 | PHARMACIA & UPJOHN COMPANY | Substituted (s)-3-phenylpiperidine derivatives, their preparation and their use as dopamine autoreceptor antagonists |
| JPH06509069A (ja) | 1991-06-27 | 1994-10-13 | バージニア・コモンウェルス・ユニバーシティ | シグマレセプターリガンドおよびその用途 |
| IE914218A1 (en) | 1991-09-11 | 1993-03-24 | Mcneilab Inc | Novel 4-arylpiperazines and 4-arylpiperidines |
| PT533268E (pt) | 1991-09-18 | 2002-02-28 | Glaxo Group Ltd | Derivados de benzanilida como antagonistas de 5-ht1d |
| GB9119932D0 (en) | 1991-09-18 | 1991-10-30 | Glaxo Group Ltd | Chemical compounds |
| GB9119920D0 (en) | 1991-09-18 | 1991-10-30 | Glaxo Group Ltd | Chemical compounds |
| US5502050A (en) | 1993-11-29 | 1996-03-26 | Cornell Research Foundation, Inc. | Blocking utilization of tetrahydrobiopterin to block induction of nitric oxide synthesis |
| EP0659743A1 (en) | 1993-12-27 | 1995-06-28 | Hoechst Aktiengesellschaft | Piperidine derivatives as inhibitors of platelet aggregation and their preparation |
| CA2144669A1 (en) | 1994-03-29 | 1995-09-30 | Kozo Akasaka | Biphenyl derivatives |
| IL114027A (en) | 1994-06-08 | 1999-11-30 | Lundbeck & Co As H | 4-Phenyl piperazine (piperidine or tetrahydropyridine) derivatives serotinin 5-HT1A and dopamin D2 receptor ligand pharmaceutical compositions containing them |
| WO1997003986A1 (fr) | 1995-07-19 | 1997-02-06 | Yoshitomi Pharmaceutical Industries, Ltd. | Composes fusionnes de triazole |
| US5892041A (en) | 1996-08-12 | 1999-04-06 | Neurogen Corporation | Fused indolecarboxamides: dopamine receptor subtype specific ligands |
| DE19637237A1 (de) | 1996-09-13 | 1998-03-19 | Merck Patent Gmbh | Piperazin-Derivate |
| PT994872E (pt) | 1997-06-10 | 2001-09-28 | Synthon Bv | Composto de 4-fenilpiperidina |
| US6232326B1 (en) | 1998-07-14 | 2001-05-15 | Jodi A. Nelson | Treatment for schizophrenia and other dopamine system dysfunctions |
| JP2000086603A (ja) | 1998-07-15 | 2000-03-28 | Yoshitomi Pharmaceut Ind Ltd | 桂皮酸アミド誘導体および３―フェニルプロピオン酸アミド誘導体 |
| DE60025604T2 (de) | 1999-06-22 | 2006-07-27 | Neurosearch A/S | Benzimidazol-derivate und diese enthaltende pharmazeutische zusammensetzungen |
| SE9904724D0 (sv) | 1999-12-22 | 1999-12-22 | Carlsson A Research Ab | New modulators of dopamine neurotransmission I |
| SE9904723D0 (sv) * | 1999-12-22 | 1999-12-22 | Carlsson A Research Ab | New modulators of dopamine neurotransmission II |
| WO2002005819A1 (en) | 2000-07-15 | 2002-01-24 | Smithkline Beecham Corporation | Compounds and methods |
| ES2247298T3 (es) | 2001-01-23 | 2006-03-01 | Eli Lilly And Company | Derivados de piperazina y piperidina como agonistas del receptor de melanocortina. |
| US20050004164A1 (en) | 2003-04-30 | 2005-01-06 | Caggiano Thomas J. | 2-Cyanopropanoic acid amide and ester derivatives and methods of their use |
| US7160888B2 (en) | 2003-08-22 | 2007-01-09 | Warner Lambert Company Llc | [1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia |
| SE0401465D0 (sv) | 2004-06-08 | 2004-06-08 | Carlsson A Research Ab | New substituted piperdines as modulators of dopamine neurotransmission |
| MXPA06013944A (es) | 2004-06-08 | 2007-10-08 | Neurosearch Sweden Ab | Nuevas fenilpiperidinas/piperazinas disustituidas como moduladores de la neurotransmision de dopamina. |
| PT1773772E (pt) | 2004-06-08 | 2010-10-04 | Nsab Af Neurosearch Sweden Ab | Novas fenilpiperidinas/piperazinas dissubstituídas como moduladores de neurotransmissão de dopamina |
| EP1796669B1 (en) | 2004-10-01 | 2010-09-22 | Merck Sharp & Dohme Corp. | Aminopiperidines as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes |
| AU2005293755A1 (en) * | 2004-10-13 | 2006-04-20 | Nsab, Filial Af Neurosearch Sweden Ab, Sverige | Process for the synthesis of 4-(3-sulfonylphenyl)-piperidines |
| RU2008101923A (ru) | 2005-08-05 | 2009-09-10 | Астразенека Аб (Se) | Трициклические бензимидазолы и их применение в качестве модуляторов метаботропного глутаматного рецептора |
| EP1963268B1 (en) | 2005-12-07 | 2010-12-01 | NSAB, Filial af NeuroSearch Sweden AB, Sverige | Disubstituted phenylpiperidines as modulators of cortical catecholaminergic neurotransmission |
-
2005
- 2005-10-13 SE SE0502254A patent/SE529246C2/sv unknown
-
2006
- 2006-10-12 AT AT06806224T patent/ATE494277T1/de active
- 2006-10-12 EP EP06806224A patent/EP1948606B1/en active Active
- 2006-10-12 ES ES06806224T patent/ES2358537T3/es active Active
- 2006-10-12 AU AU2006301432A patent/AU2006301432B2/en not_active Ceased
- 2006-10-12 JP JP2008534935A patent/JP4857346B2/ja not_active Expired - Fee Related
- 2006-10-12 MY MYPI20081021A patent/MY143241A/en unknown
- 2006-10-12 WO PCT/EP2006/009866 patent/WO2007042295A1/en active Application Filing
- 2006-10-12 KR KR1020087008815A patent/KR20080046720A/ko active IP Right Grant
- 2006-10-12 BR BRPI0617355-1A patent/BRPI0617355A2/pt not_active IP Right Cessation
- 2006-10-12 NZ NZ566015A patent/NZ566015A/en not_active IP Right Cessation
- 2006-10-12 PL PL06806224T patent/PL1948606T3/pl unknown
- 2006-10-12 US US12/089,412 patent/US8501777B2/en active Active
- 2006-10-12 CN CN2006800352682A patent/CN101273014B/zh not_active Expired - Fee Related
- 2006-10-12 ZA ZA200802238A patent/ZA200802238B/xx unknown
- 2006-10-12 DK DK06806224.9T patent/DK1948606T3/da active
- 2006-10-12 CA CA002625663A patent/CA2625663A1/en not_active Abandoned
- 2006-10-12 RU RU2008108618/04A patent/RU2418787C2/ru not_active IP Right Cessation
- 2006-10-12 DE DE602006019470T patent/DE602006019470D1/de active Active
- 2006-12-10 UA UAA200801380A patent/UA93380C2/ru unknown
-
2008
- 2008-02-05 IL IL189298A patent/IL189298A0/en unknown
- 2008-05-09 NO NO20082174A patent/NO20082174L/no not_active Application Discontinuation
-
2009
- 2009-03-12 HK HK09102390.3A patent/HK1125097A1/xx not_active IP Right Cessation
-
2011
- 2011-03-16 HR HR20110196T patent/HRP20110196T1/hr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| RU2418787C2 (ru) | 2011-05-20 |
| CN101273014A (zh) | 2008-09-24 |
| CA2625663A1 (en) | 2007-04-19 |
| SE529246C2 (sv) | 2007-06-12 |
| IL189298A0 (en) | 2008-06-05 |
| HRP20110196T1 (hr) | 2011-05-31 |
| CN101273014B (zh) | 2011-01-12 |
| NZ566015A (en) | 2010-11-26 |
| JP2009511525A (ja) | 2009-03-19 |
| US8501777B2 (en) | 2013-08-06 |
| NO20082174L (no) | 2008-07-11 |
| ATE494277T1 (de) | 2011-01-15 |
| US20080234321A1 (en) | 2008-09-25 |
| KR20080046720A (ko) | 2008-05-27 |
| EP1948606B1 (en) | 2011-01-05 |
| AU2006301432A1 (en) | 2007-04-19 |
| ZA200802238B (en) | 2009-10-28 |
| ES2358537T3 (es) | 2011-05-11 |
| WO2007042295A1 (en) | 2007-04-19 |
| DE602006019470D1 (de) | 2011-02-17 |
| JP4857346B2 (ja) | 2012-01-18 |
| SE0502254L (sv) | 2007-04-14 |
| MY143241A (en) | 2011-04-15 |
| UA93380C2 (en) | 2011-02-10 |
| AU2006301432B2 (en) | 2011-12-15 |
| DK1948606T3 (da) | 2011-04-04 |
| BRPI0617355A2 (pt) | 2011-07-26 |
| HK1125097A1 (en) | 2009-07-31 |
| EP1948606A1 (en) | 2008-07-30 |
| RU2008108618A (ru) | 2009-11-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1125097A1 (en) | 3,5-disubstituted phenyl-piperidines as modulators of dopamine neurotransmission | |
| GB0510141D0 (en) | Novel compounds B3 | |
| GB0510143D0 (en) | Novel compounds A1 | |
| MX2007014405A (es) | Novedosos derivados de oxadiazol y su uso como moduladores aloestericos positivos de los receptores de glutamato metabotropicos. | |
| UA87856C2 (ru) | Алкильные производные как модуляторы метаботропных рецепторов глутамата | |
| MX2007014444A (es) | Derivados de oxadiazol sustituido como moduladores aloestericos positivos de los receptores de glutamato metabotropicos. | |
| SE0401465D0 (sv) | New substituted piperdines as modulators of dopamine neurotransmission | |
| TW200510301A (en) | Novel compounds | |
| TW200510303A (en) | Novel compounds | |
| BRPI0916235B8 (pt) | composto, composição farmacêutica, e, uso do composto ou da composição | |
| SG10201809390QA (en) | Modulators of indoleamine 2,3-dioxygenase and methods of using the same | |
| EA200700909A1 (ru) | Азаиндолкарбоксамиды | |
| IL176111A0 (en) | 2-(1h-indolylsulfanyl)-benzyl amine derivatives as ssri | |
| WO2007138282A3 (en) | Bi-aryl or aryl-heteroaryl substituted indoles | |
| ATE467632T1 (de) | Pyrroloä2,3-büpyridinderivate als modulatoren des h3-rezeptors | |
| MX2008013196A (es) | 5-amido-2-carboxiamida-indoles. | |
| NO20082096L (no) | Azaindol-2-karboksamidderivativer | |
| WO2008045371A3 (en) | N-substituted-azacyclylamines as histamine-3 antagonists | |
| TW200740766A (en) | Substituted-3-sulfonylindazole derivatives as 5-hydroxytryptamine-6-ligands | |
| MXPA06013945A (es) | Piperidinas sustituidas, novedosas, como moduladores de la neurotransmision de dopamina. | |
| DE602007008947D1 (en) | 4,5,6,7-tetrahydrothienoä2,3-cüpyridine als h3-modulatoren | |
| TW200616637A (en) | Novel quinoxalinone norepinephrine reuptake inhibitors for the treatment of central nervous system disorders | |
| ATE502947T1 (de) | 4,5,6,7-tetrahydrothienoä3,2-cüpyridinderivate als h3-modulatoren | |
| UA87853C2 (en) | Disubstituted phenylpiperidines/piperazines as modulators of dopamine neurotransmission | |
| UA92495C2 (ru) | Замещенные производные оксадиазола как положительные аллостерические модуляторы метаботропных глутаматных рецепторов |